NuCana BioMed is an emerging biopharmaceutical company dedicated to the discovery, development and commercialisation of innovative, rationally designed medicines that address significant unmet medical needs. Our management team has extensive experience of building successful biopharmaceutical companies. This includes the formation and subsequent growth of Bioenvision into a NASDAQ National listed, global biopharmaceutical company, which was acquired by Genzyme Corporation in October 2007. Specific management expertise includes the development, approval and commercialisation of oncology medicines. We are developing a portfolio of first-in-class and best-in-class pharmaceutical products designed to treat life-threatening or debilitating diseases. Our primary focus is in the area of oncology, although our technology platform has broader clinical potential.
Current Team (3)Update
Funding Rounds (2) - $67.5MUpdate
Board Members and Advisors (3)Update
Investment Arm of Scottish Enterprise
Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...
Identify and exploit opportunities
Morningside Group is a private investment group founded in 1986 by the Chan family of Hong Kong.
Sofinnova Partners is an independent venture capital firm based in Paris, France. For over 35...
10 Lochside Place
Edinburgh, EH12 9RG